|
Arix Bioscience PLC
Arix Bioscience PLC: Director/PDMR Shareholdings
17-Dec-2021 / 11:12 GMT/BST
Arix Bioscience plc
Director/PDMR Shareholdings
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Robert Lyne
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
CEO and General Counsel
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Arix Bioscience plc
|
|
b)
|
LEI
|
213800OVT3AHQCXNIX43
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
|
Arix Bioscience plc Ordinary shares of 0.001 pence each
|
|
|
|
|
Identification code
|
GB00BD045071
|
|
b)
|
Nature of the transaction
|
Share purchase
|
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
120.00p
|
41,666.00
|
|
|
d)
|
Aggregated information
|
|
|
|
|
|
- Aggregated volume
|
N/A single transaction
|
|
|
|
|
- Price
|
£49,999.20
|
|
|
|
|
e)
|
Date of the transaction
|
16 December 2021
|
|
f)
|
Place of the transaction
|
London Stock Exchange
|
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Peregrine Moncreiffe
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director and Chair of the Board
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Arix Bioscience plc
|
|
b)
|
LEI
|
213800OVT3AHQCXNIX43
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
|
Arix Bioscience plc Ordinary shares of 0.001 pence each
|
|
|
|
|
Identification code
|
GB00BD045071
|
|
b)
|
Nature of the transaction
|
Share purchase
|
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
119.00p
|
84,000.00
|
|
|
d)
|
Aggregated information
|
|
|
|
|
|
- Aggregated volume
|
N/A single transaction
|
|
|
|
|
- Price
|
£99,959.98
|
|
|
|
|
e)
|
Date of the transaction
|
16 December 2021
|
|
f)
|
Place of the transaction
|
London Stock Exchange
|
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Sir Michael Bunbury
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director and Senior Independent Director (SID)
|
|
b)
|
Initial notification /Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Arix Bioscience plc
|
|
b)
|
LEI
|
213800OVT3AHQCXNIX43
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
|
Arix Bioscience plc Ordinary shares of 0.001 pence each
|
|
|
|
|
Identification code
|
GB00BD045071
|
|
b)
|
Nature of the transaction
|
Share purchase
|
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
119.00p
|
40,000.00
|
|
|
d)
|
Aggregated information
|
|
|
|
|
|
- Aggregated volume
|
N/A single transaction
|
|
|
|
|
- Price
|
£47,600.00
|
|
|
|
|
e)
|
Date of the transaction
|
16 December 2021
|
|
f)
|
Place of the transaction
|
London Stock Exchange
|
For further information please contact:
Derringtons Limited, Company Secretary
+44 20 8819 6486
Ends.
Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
|
End of Announcement - EQS News Service
1259488 17-Dec-2021
Der finanzen.at Ratgeber für Aktien!
ETF-Sparplan